{"hands_on_practices": [{"introduction": "The future of preventive medicine lies in precision: identifying the right individuals for the right intervention. This practice explores the mathematical foundation of risk-stratified screening, a core component of this new paradigm. By deriving the relationship between a test's Positive Predictive Value ($PPV$) and disease prevalence, you will see how targeting high-risk populations fundamentally enhances the utility of diagnostic and screening tools. [@problem_id:4527017]", "problem": "A health system planning next-generation, risk-stratified screening in preventive medicine is considering how targeted selection (for example, using polygenic risk scores and continuous digital phenotyping) will alter the pre-test probability of disease. Let $D$ denote the event that an individual has the disease screened for, and let $T^{+}$ denote a positive result on a binary screening test. The Positive Predictive Value (PPV) is defined as $PPV = P(D \\mid T^{+})$. The Sensitivity (Se) and Specificity (Sp) of the screening test are defined as $Se = P(T^{+} \\mid D)$ and $Sp = P(T^{-} \\mid \\overline{D})$, respectively, where $\\overline{D}$ denotes the complement of $D$.\n\nStarting only from Bayesâ€™ rule and the law of total probability, derive algebraically how $PPV$ depends on the disease prevalence $P(D)$, $Se$, and $Sp$ for this binary screening test. Then, assuming $Se$ and $Sp$ are fixed characteristics of the test while prevalence $P(D)$ varies due to risk stratification, compute the derivative $\\frac{d\\,PPV}{d\\,P(D)}$ in closed form. Express your final answer as a single analytic expression in terms of $Se$, $Sp$, and $P(D)$. No rounding is required, and no units are needed for the final expression.", "solution": "The problem is valid as it is scientifically grounded in the principles of probability theory and epidemiology, is well-posed with all necessary information provided, and is entirely objective.\n\nThe first task is to derive an algebraic expression for the Positive Predictive Value ($PPV$) in terms of disease prevalence $P(D)$, sensitivity ($Se$), and specificity ($Sp$). We begin with the definition of $PPV$:\n$$PPV = P(D \\mid T^{+})$$\nwhere $D$ is the event of having the disease and $T^{+}$ is the event of a positive test result.\n\nUsing Bayes' rule, we can express this conditional probability as:\n$$P(D \\mid T^{+}) = \\frac{P(T^{+} \\mid D) P(D)}{P(T^{+})}$$\n\nThe terms in the numerator are given or directly related to the given quantities. $P(T^{+} \\mid D)$ is the definition of sensitivity, $Se$. $P(D)$ is the prevalence of the disease. So, the numerator is $Se \\cdot P(D)$.\n\nThe denominator, $P(T^{+})$, is the overall probability of a positive test result. We can expand this term using the law of total probability, conditioning on whether an individual has the disease ($D$) or not ($\\overline{D}$):\n$$P(T^{+}) = P(T^{+} \\mid D) P(D) + P(T^{+} \\mid \\overline{D}) P(\\overline{D})$$\n\nWe can substitute the known quantities into this expression:\n1. $P(T^{+} \\mid D) = Se$ (Sensitivity).\n2. $P(D)$ is the prevalence.\n3. $P(\\overline{D}) = 1 - P(D)$, as $\\overline{D}$ is the complement of $D$.\n4. $P(T^{+} \\mid \\overline{D})$ must be derived from specificity, $Sp$. Specificity is defined as $Sp = P(T^{-} \\mid \\overline{D})$, where $T^{-}$ is a negative test result. Since the test is binary, for a person without the disease, the test can only be positive or negative. Therefore, $P(T^{+} \\mid \\overline{D}) + P(T^{-} \\mid \\overline{D}) = 1$. This gives us $P(T^{+} \\mid \\overline{D}) = 1 - Sp$. This term is also known as the false positive rate.\n\nSubstituting these components back into the equation for $P(T^{+})$ yields:\n$$P(T^{+}) = Se \\cdot P(D) + (1 - Sp) (1 - P(D))$$\n\nNow, we substitute the expressions for the numerator and the denominator back into the Bayes' rule formula for $PPV$:\n$$PPV = \\frac{Se \\cdot P(D)}{Se \\cdot P(D) + (1 - Sp) (1 - P(D))}$$\nThis is the required expression for $PPV$ as a function of $P(D)$, $Se$, and $Sp$.\n\nThe second task is to compute the derivative $\\frac{d\\,PPV}{d\\,P(D)}$, assuming $Se$ and $Sp$ are fixed constants. For notational convenience, let $p = P(D)$. The expression for $PPV$ becomes:\n$$PPV(p) = \\frac{Se \\cdot p}{Se \\cdot p + (1 - Sp)(1 - p)}$$\nTo find the derivative with respect to $p$, we use the quotient rule for differentiation, which states that for a function $f(p) = \\frac{u(p)}{v(p)}$, the derivative is $f'(p) = \\frac{u'(p)v(p) - u(p)v'(p)}{[v(p)]^2}$.\n\nLet us define the numerator and denominator functions:\n- $u(p) = Se \\cdot p$\n- $v(p) = Se \\cdot p + (1 - Sp)(1 - p)$\n\nFirst, we find their derivatives with respect to $p$:\n- $u'(p) = \\frac{d}{dp}(Se \\cdot p) = Se$\n- To find $v'(p)$, we can first expand $v(p)$:\n  $v(p) = Se \\cdot p + 1 - p - Sp + Sp \\cdot p = (Se + Sp - 1)p + (1 - Sp)$\n  Then, the derivative is:\n  $v'(p) = \\frac{d}{dp}((Se + Sp - 1)p + (1 - Sp)) = Se + Sp - 1$\n\nNow, we apply the quotient rule:\n$$\\frac{d(PPV)}{dp} = \\frac{u'(p)v(p) - u(p)v'(p)}{[v(p)]^2}$$\n$$\\frac{d(PPV)}{dp} = \\frac{(Se)[Se \\cdot p + (1 - Sp)(1 - p)] - (Se \\cdot p)(Se + Sp - 1)}{[Se \\cdot p + (1 - Sp)(1 - p)]^2}$$\n\nLet's simplify the numerator:\nNumerator $= Se \\cdot [Se \\cdot p + (1 - Sp)(1-p)] - Se \\cdot p \\cdot (Se + Sp - 1)$\nNumerator $= Se^2 \\cdot p + Se(1 - Sp)(1-p) - Se^2 \\cdot p - Se \\cdot Sp \\cdot p + Se \\cdot p$\nNumerator $= Se(1 - Sp)(1 - p) - Se \\cdot Sp \\cdot p + Se \\cdot p$\nNumerator $= Se(1 - Sp - p + p \\cdot Sp) - Se \\cdot Sp \\cdot p + Se \\cdot p$\nNumerator $= Se - Se \\cdot Sp - Se \\cdot p + Se \\cdot p \\cdot Sp - Se \\cdot Sp \\cdot p + Se \\cdot p$\n\nLet's use the simplified form of $v(p)$ for an easier algebraic manipulation of the numerator:\nNumerator $= u'v - uv'$\nNumerator $= Se \\cdot [(Se + Sp - 1)p + (1 - Sp)] - (Se \\cdot p)(Se + Sp - 1)$\nNumerator $= Se(Se + Sp - 1)p + Se(1 - Sp) - Se(Se + Sp - 1)p$\nThe first and third terms cancel each other out, leaving:\nNumerator $= Se(1 - Sp)$\n\nThe denominator is $[v(p)]^2$. Substituting the original expression for $v(p)$ and $p=P(D)$, we obtain the final expression for the derivative:\n$$\\frac{d\\,PPV}{d\\,P(D)} = \\frac{Se(1 - Sp)}{[Se \\cdot P(D) + (1 - Sp)(1 - P(D))]^2}$$\nThis is the closed-form analytical expression for the derivative of the Positive Predictive Value with respect to the prevalence of the disease.", "answer": "$$ \\boxed{\\frac{Se(1 - Sp)}{[Se \\cdot P(D) + (1 - Sp)(1 - P(D))]^{2}}} $$", "id": "4527017"}, {"introduction": "An intervention's success is not just about its theoretical efficacy but its effectiveness in the real world, where adherence is never perfect. This exercise provides a crucial tool for translating ideal-case results into realistic population-level impact, a vital step in evaluating modern digital health programs. You will learn how to model and calculate an adherence-adjusted risk ratio, accounting for the inevitable gap between protocol and practice. [@problem_id:4527053]", "problem": "A public health system is piloting a smartphone-guided physical activity program to prevent incident Type 2 Diabetes Mellitus, leveraging continuous adherence monitoring via wearable sensors. In early trials, among participants who followed the protocol as prescribed, the intervention produced a risk ratio ($RR$) of $RR=0.7$ for developing Type 2 Diabetes Mellitus compared to standard care. In anticipated real-world deployment using adaptive coaching, the system estimates that the adherence proportion will be $a=0.6$, meaning a fraction $a$ of participants will achieve the prescribed activity dose while the remaining fraction $1-a$ will not materially change their activity levels.\n\nUsing only fundamental definitions of risk, risk ratio, and a mixture model for subpopulations, derive an expression for the adherence-adjusted population-level risk ratio $RR_{adj}$ relative to baseline and compute its value for $RR=0.7$ and $a=0.6$. Round your computed adherence-adjusted risk ratio to three significant figures. Then, briefly interpret the prevention impact in words (no numerical interpretation is required in the final answer).", "solution": "The problem statement is subjected to validation before a solution is attempted.\n\n### Step 1: Extract Givens\n- Risk ratio for adherent participants: $RR = 0.7$.\n- Adherence proportion: $a = 0.6$.\n- The remaining fraction of participants, $1-a$, will not materially change their activity levels.\n- The objective is to derive an expression for the adherence-adjusted population-level risk ratio, $RR_{adj}$, and to compute its value.\n- The computed value must be rounded to three significant figures.\n- A brief verbal interpretation of the prevention impact is required in the solution body.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed for validity against the specified criteria.\n- **Scientifically Grounded**: The concepts of risk, risk ratio ($RR$), and adherence are fundamental to epidemiology and clinical trial analysis. The use of a mixture model to account for subpopulations (adherent vs. non-adherent) is a standard and valid approach for estimating population-level or intention-to-treat effects. The numerical values provided ($RR=0.7$, $a=0.6$) are plausible for a behavioral health intervention. The problem is scientifically sound.\n- **Well-Posed**: The problem provides all necessary information to derive the required expression and compute the value. The statement that non-adherent participants \"will not materially change their activity levels\" provides a clear, formalizable assumption: their risk is equivalent to the baseline risk. The objective is unambiguous. The problem is well-posed.\n- **Objective**: The problem is stated using precise, quantitative language and established epidemiological terms. It is free of subjective or opinion-based content.\n\n### Step 3: Verdict and Action\nThe problem is valid. It is scientifically grounded, well-posed, and objective. A solution will be derived.\n\n### Solution Derivation\nThe objective is to derive the adherence-adjusted population-level risk ratio, $RR_{adj}$. We begin by defining the fundamental terms.\n\nLet $R_0$ denote the baseline risk of developing Type 2 Diabetes Mellitus in the control group (standard care).\nLet $R_{int}$ denote the overall risk in the intervention group, which is a mixed population.\n\nThe adherence-adjusted risk ratio is defined as the ratio of the risk in the total intervention group to the risk in the control group:\n$$RR_{adj} = \\frac{R_{int}}{R_0}$$\n\nThe intervention group consists of two distinct subpopulations:\n1. A fraction $a$ of participants who are adherent to the protocol.\n2. A fraction $1-a$ of participants who are non-adherent.\n\nThe risk for the adherent subpopulation, $R_{adherent}$, can be expressed using the given risk ratio, $RR$, for this group:\n$$R_{adherent} = RR \\times R_0$$\n\nThe problem states that the non-adherent participants \"will not materially change their activity levels.\" This implies their risk is identical to the baseline risk of the control group. Therefore, the risk for the non-adherent subpopulation, $R_{non-adherent}$, is:\n$$R_{non-adherent} = R_0$$\nThis is equivalent to stating that the risk ratio for the non-adherent subgroup relative to the control group is $1$.\n\nThe overall risk in the intervention group, $R_{int}$, is the weighted average of the risks of the two subpopulations, where the weights are their respective proportions in the group:\n$$R_{int} = (a \\times R_{adherent}) + ((1-a) \\times R_{non-adherent})$$\n\nSubstituting the expressions for $R_{adherent}$ and $R_{non-adherent}$:\n$$R_{int} = (a \\times RR \\times R_0) + ((1-a) \\times R_0)$$\n\nWe can factor out the baseline risk, $R_0$:\n$$R_{int} = R_0 \\times (a \\times RR + 1 - a)$$\n\nNow, we can derive the expression for $RR_{adj}$ by substituting this expression for $R_{int}$ into its definition:\n$$RR_{adj} = \\frac{R_0 \\times (a \\times RR + 1 - a)}{R_0}$$\n\nCanceling the $R_0$ term from the numerator and denominator yields the general expression for the adherence-adjusted risk ratio:\n$$RR_{adj} = a \\times RR + 1 - a$$\n\nNext, we compute the numerical value of $RR_{adj}$ using the given values $RR=0.7$ and $a=0.6$:\n$$RR_{adj} = (0.6) \\times (0.7) + (1 - 0.6)$$\n$$RR_{adj} = 0.42 + 0.4$$\n$$RR_{adj} = 0.82$$\n\nThe problem requires the answer to be rounded to three significant figures. The value $0.82$ is written as $0.820$ to meet this requirement.\n\n### Interpretation\nThe derived adherence-adjusted risk ratio, $RR_{adj} = 0.820$, represents the expected risk ratio at the population level when the intervention is deployed, accounting for incomplete adherence. A risk ratio of $1.0$ indicates no difference in risk between the intervention and control groups. The risk ratio of $0.7$ for perfect adherers indicates a $30\\%$ risk reduction. However, because only $60\\%$ of the population adheres, the effect is attenuated. The resulting population-level risk ratio of $0.820$ signifies an average risk reduction of $1 - 0.820 = 0.18$, or $18\\%$, across the entire intervention population compared to standard care. This demonstrates that the effectiveness of an intervention in a real-world setting is diluted by non-adherence.", "answer": "$$\\boxed{0.820}$$", "id": "4527053"}, {"introduction": "Effective preventive strategies must also be economically sustainable over the long term, delivering value for health systems and society. This practice introduces the fundamental economic principle of discounting, which allows us to compare costs and health benefits that occur at different points in time. By calculating the present value of a stream of costs and Quality-Adjusted Life Years (QALYs), you will gain a core skill for health technology assessment and resource allocation decisions. [@problem_id:4527040]", "problem": "A city health department plans to scale a Precision Prevention program that uses continuous digital monitoring and behavioral nudges to reduce cardiometabolic risk. To evaluate long-run value under standard intertemporal decision-making, assume a constant annual discount rate $r=0.03$ with discrete annual compounding and end-of-year accrual. For a representative participant, the program is expected to generate a constant stream of $0.2$ Quality-Adjusted Life Year (QALY) per year and require a constant stream of $C=5000$ dollars per year, each over a horizon of $t=10$ years. A Quality-Adjusted Life Year (QALY) is defined as the integral of health-state utility over time, so that a constant incremental utility stream yields a constant QALY accrual per unit time.\n\nStarting from the fundamental definition that the present value of a future end-of-year quantity $X$ received in year $k$ is $X$ multiplied by the discount factor, and using the general definition of discrete-time discounting under constant time preference, derive from first principles a closed-form expression for the present value of a constant end-of-year stream over a finite horizon. Then apply it to compute the present value of QALYs and the present value of costs for the given streams and horizon.\n\nReport your final numerical results as a two-entry row matrix, with the first entry equal to the present value of QALYs (in QALYs) and the second entry equal to the present value of costs (in dollars). Round each entry to four significant figures. Do not include units inside the matrix.", "solution": "The core objective is to value constant streams occurring at the end of each year over a finite horizon under discrete-time discounting. We begin with two foundational definitions.\n\nFirst, a Quality-Adjusted Life Year (QALY) is the integral of health-state utility over time. When an intervention yields a constant incremental utility stream that is converted to QALYs at a constant rate, the undiscounted QALY accrual over $n$ years is $n$ times the annual QALY increment. In this problem, the annual increment is $0.2$ QALY per year.\n\nSecond, under discrete-time discounting with constant annual rate $r$, the present value of a quantity $X$ received at the end of year $k$ is given by $X$ multiplied by the discount factor $d_{k}$, where\n$$\nd_{k} = \\frac{1}{(1+r)^{k}}.\n$$\nThis follows from the fundamental time preference and opportunity cost of capital principles: a unit of payoff realized in the future is valued less today by a factor equal to the inverse of the gross accumulation factor $(1+r)$ applied for $k$ periods.\n\nConsider a constant end-of-year stream with amount $A$ per year for $n$ years. The present value $\\mathrm{PV}(A;n,r)$ is\n$$\n\\mathrm{PV}(A;n,r) = \\sum_{k=1}^{n} \\frac{A}{(1+r)^{k}} = A \\sum_{k=1}^{n} \\left(\\frac{1}{1+r}\\right)^{k}.\n$$\nLet $q = \\frac{1}{1+r}$. The sum is a finite geometric series with first term $q$, ratio $q$, and $n$ terms. The geometric series sum formula gives\n$$\n\\sum_{k=1}^{n} q^{k} = q \\cdot \\frac{1 - q^{n}}{1 - q}.\n$$\nSubstituting $q = \\frac{1}{1+r}$ yields\n$$\n\\sum_{k=1}^{n} \\left(\\frac{1}{1+r}\\right)^{k}\n= \\frac{1}{1+r} \\cdot \\frac{1 - \\left(\\frac{1}{1+r}\\right)^{n}}{1 - \\frac{1}{1+r}}\n= \\frac{1 - (1+r)^{-n}}{r}.\n$$\nTherefore, the closed-form present value for a constant end-of-year stream is\n$$\n\\mathrm{PV}(A;n,r) = A \\cdot \\frac{1 - (1+r)^{-n}}{r}.\n$$\n\nWe now apply this to the two streams in the problem with $r=0.03$ and $n=t=10$:\n- Annual QALY stream: $A_{Q} = 0.2$ QALY per year.\n- Annual cost stream: $A_{C} = 5000$ dollars per year.\n\nFirst compute the common present value factor $S(n,r)$:\n$$\nS(10,0.03) = \\frac{1 - (1+0.03)^{-10}}{0.03}.\n$$\nCompute $(1+0.03)^{10}$:\n$$\n(1.03)^{10} \\approx 1.3439163793,\n$$\nso\n$$\n(1.03)^{-10} \\approx \\frac{1}{1.3439163793} \\approx 0.744094.\n$$\nThen\n$$\n1 - (1.03)^{-10} \\approx 1 - 0.744094 = 0.255906,\n$$\nand\n$$\nS(10,0.03) \\approx \\frac{0.255906}{0.03} \\approx 8.5302.\n$$\n\nPresent value of QALYs:\n$$\n\\mathrm{PV}_{\\text{QALY}} = A_{Q} \\cdot S(10,0.03) \\approx 0.2 \\times 8.5302 = 1.70604 \\text{ QALYs}.\n$$\nRounded to four significant figures:\n$$\n\\mathrm{PV}_{\\text{QALY}} \\approx 1.706 \\text{ QALYs}.\n$$\n\nPresent value of costs:\n$$\n\\mathrm{PV}_{\\text{Cost}} = A_{C} \\cdot S(10,0.03) \\approx 5000 \\times 8.5302 = 42651 \\text{ dollars}.\n$$\nRounded to four significant figures, this is\n$$\n\\mathrm{PV}_{\\text{Cost}} \\approx 4.265 \\times 10^{4} \\text{ dollars}.\n$$\n\nPer the reporting instruction, we present the two results as a row matrix, first the present value of QALYs (in QALYs) and second the present value of costs (in dollars), with each entry rounded to four significant figures and omitting units inside the matrix.", "answer": "$$\\boxed{\\begin{pmatrix}1.706  4.265 \\times 10^{4}\\end{pmatrix}}$$", "id": "4527040"}]}